Article Information
History
- July 26, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Rishi K. Gupta1,2,
- Michael Marks2,3,
- Thomas H. A. Samuels2,
- Akish Luintel2,
- Tommy Rampling2,
- Humayra Chowdhury2,
- Matteo Quartagno4,
- Arjun Nair2,
- Marc Lipman5,
- Ibrahim Abubakar1,
- Maarten van Smeden6,
- Wai Keong Wong2,
- Bryan Williams7,8 and
- Mahdad Noursadeghi2,9,†
- on behalf of The UCLH COVID-19 Reporting Group*
- 1Institute for Global Health, University College London, London, UK
- 2University College London Hospitals NHS Trust
- 3Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK
- 4MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK
- 5UCL Respiratory, Division of Medicine, University College London, London, UK
- 6Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- 7NIHR University College London Hospitals Biomedical Research Centre
- 8University College London, London, UK
- 9Division of Infection & Immunity, University College London, UK
- ↵†Correspondence Prof Mahdad Noursadeghi, Division of Infection & Immunity, Cruciform Building, University College London, London WC1E 6BT, United Kingdom. Telephone: +442031082128. Email: m.noursadeghi{at}ucl.ac.uk